This is a multicenter, phase II, three-arm, randomized, double-blind trial that will compare the efficacy of therapy with Ziodovudine (ZDV) alone with that of 2',3'-dideoxyinosine (ddi) alone and with that of ZDV plus ddi. The study will also compare the safety and tolerance of these three arms.
Showing the most recent 10 out of 470 publications